This question tests critical care skills in managing sepsis and severe infections. Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Early recognition and management are crucial to improve outcomes. In the presented scenario, the patient's symptoms and lab findings suggest sepsis, highlighting the need for rapid intervention. Choice B is correct because it aligns with the guidelines for initial sepsis management, emphasizing the importance of biliary decompression via ERCP in cholangitis. Choice A is incorrect because it reflects a common misconception, such as delaying intervention for elective surgery. To help students: Emphasize the importance of early recognition and rapid intervention in sepsis. Teach prioritization of interventions and the use of current guidelines. Encourage practice with clinical scenarios to improve decision-making.

This question tests critical care skills in managing sepsis and severe infections. Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Early recognition and management are crucial to improve outcomes. In the presented scenario, the patient's symptoms and lab findings suggest sepsis, highlighting the need for rapid intervention. Choice B is correct because it aligns with the guidelines for initial sepsis management, emphasizing the importance of drainage with step-up approach for infected necrosis. Choice A is incorrect because it reflects a common misconception, such as avoiding drainage to prevent fistulas, which delays source control. To help students: Emphasize the importance of early recognition and rapid intervention in sepsis. Teach prioritization of interventions and the use of current guidelines. Encourage practice with clinical scenarios to improve decision-making.

This question tests critical care skills in managing sepsis and severe infections. Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Early recognition and management are crucial to improve outcomes. In the presented scenario, the patient's symptoms and lab findings suggest sepsis, highlighting the need for rapid intervention. Choice B is correct because it aligns with the guidelines for initial sepsis management, emphasizing the importance of vasopressor therapy with norepinephrine after initial fluid resuscitation. Choice C is incorrect because it reflects a common misconception, such as preferring dopamine as first-line, which is not recommended due to arrhythmia risks. To help students: Emphasize the importance of early recognition and rapid intervention in sepsis. Teach prioritization of interventions and the use of current guidelines. Encourage practice with clinical scenarios to improve decision-making.

This patient has septic shock from a healthcare-associated infection (catheter-associated UTI from a long-term care facility). Empiric therapy must cover common uropathogens, including multidrug-resistant organisms like Pseudomonas aeruginosa. Piperacillin-tazobactam is a broad-spectrum beta-lactam/beta-lactamase inhibitor that provides excellent coverage against gram-negative rods (including Pseudomonas), gram-positives, and anaerobes, making it an ideal choice. Ceftriaxone lacks reliable Pseudomonas coverage. Vancomycin is for MRSA and is not first-line for urosepsis unless a specific indication exists. Metronidazole is for anaerobic coverage and is not appropriate as monotherapy.

A fundamental principle in managing sepsis is source control. This patient has a large, drainable collection of pus (perinephric abscess) that is serving as an ongoing source of infection and inflammation. Without drainage, medical therapy (antibiotics) alone is unlikely to be successful. Therefore, the most critical next step is to arrange for drainage, typically via percutaneous catheter placement by interventional radiology. Adding antifungals or steroids is not indicated without further evidence, and while repeat cultures are useful, they do not address the primary problem of the undrained abscess.

For patients with severe community-acquired pneumonia (CAP) requiring ICU admission, especially those in septic shock, guidelines recommend combination therapy. A beta-lactam (e.g., ceftriaxone) should be combined with either a macrolide (e.g., azithromycin) or a respiratory fluoroquinolone. The combination of ceftriaxone and azithromycin provides excellent coverage for common bacterial pathogens like Streptococcus pneumoniae as well as atypical pathogens like Legionella and Mycoplasma. Vancomycin and cefepime would be for hospital-acquired pneumonia. Levofloxacin monotherapy is an option but combination is often preferred in shock. Ampicillin/sulbactam has less reliable coverage for some CAP pathogens.

This patient has a catheter-related bloodstream infection (CRBSI) due to MRSA and is clinically unstable (sepsis with persistent hypotension). Prompt removal of the infected catheter is essential for source control and is associated with improved outcomes, especially in severe infections caused by S. aureus. While antibiotic therapy is critical, it will be less effective as long as the infected foreign body remains in place. A TEE is important to rule out endocarditis, but catheter removal is the immediate priority for source control. Adjusting antibiotics is secondary to removing the source.

This patient has a complicated intra-abdominal infection (perforated diverticulitis) causing sepsis. The infection is polymicrobial, involving gram-negative rods, gram-positive cocci, and anaerobes from the colon. Empiric antibiotic therapy must cover all these organisms. Piperacillin-tazobactam is a broad-spectrum agent that provides excellent coverage for this spectrum of pathogens and is a recommended first-line agent. Ceftriaxone/azithromycin is for CAP. Vancomycin alone is inadequate. Levofloxacin alone lacks anaerobic coverage.

The Sepsis-3 international consensus definition for septic shock is a subset of sepsis in which underlying circulatory and cellular/metabolic abnormalities are profound enough to substantially increase mortality. The clinical criteria are: 1) persistent hypotension requiring vasopressors to maintain a mean arterial pressure (MAP) of 65 mmHg or greater, AND 2) a serum lactate level greater than 2 mmol/L, despite adequate fluid resuscitation. This patient has hypotension and an elevated lactate; if she requires vasopressors to raise her MAP, she will meet the criteria for septic shock.

This patient has neutropenic fever and sepsis, a life-threatening emergency. Empiric antibiotic therapy must be started immediately and must cover Pseudomonas aeruginosa, a common and virulent pathogen in this population. The standard of care for high-risk neutropenic fever is monotherapy with an antipseudomonal beta-lactam, such as cefepime, piperacillin-tazobactam, or a carbapenem. Cefepime is an excellent first-line choice. Ceftriaxone lacks reliable Pseudomonas coverage. Vancomycin is not recommended for initial empiric therapy unless there is a specific indication (e.g., suspected catheter infection, severe mucositis, skin infection).